Correction
Specific blockade of Rictor-mTOR association inhibits mTORC2 activity and is cytotoxic in glioblastoma
Paper Information
Record ID:
58803
Author(s):
Publication Date:
April 28, 2017
Retraction Date:
February 06, 2019
(6.8 years years ago)
Subjects:
Institutions:
- Department of Medicine, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, California, United States of America
- Department of Research & Development, Greater Los Angeles Veterans Affairs Healthcare System, Los Angeles, California, United States of America
- Department of Chemistry and Biochemistry, University of California-Los Angeles, Los Angeles, California, United States of America
- Jonnson Comprehensive Cancer Center, University of California-Los Angeles, Los Angeles, California, United States of America
- Molecular Biology Institute, University of California-Los Angeles, Los Angeles, California, United States of America
Country:
🇺🇸 United StatesArticle Type:
Publisher:
PLoS
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Correction Details
Retraction Reasons:
Nature of Retraction:
Correction
Retraction Notice:
10.1371/journal.pone.0212160Additional Notes:
Alan Lichtenstein has VA finding of misconduct: see https://www.federalregister.gov/documents/2024/11/18/2024-26756/findings-of-research-misconduct-c;
Citations (72)
72
Total Citations61
Post-Retraction(84.7%)
10
Pre-Retraction1
Same DayPost-Retraction Citation Analysis
1
Within 30 days
9
Within 1 year
35
After 2+ years
2147
Days since retraction (latest)
mTOR complex 2 is an integrator of cancer metabolism and epigenetics
Kenta Masui, Mio Harachi, Webster K. Cavenee et al. (5 authors)
Cancer Letters
Published: Mar 2020
33 citations
33 citations
397 days after retraction
The role of RICTOR amplification in targeted therapy and drug resistance
Deze Zhao, Man Jiang, Xiaochun Zhang et al. (4 authors)
Molecular Medicine
Open Access
Published: Feb 2020
26 citations
26 citations
369 days after retraction
Repurposing Potential of Riluzole as an ITAF Inhibitor in mTOR Therapy Resistant Glioblastoma
Angelica Benavides-Serrato, Jacquelyn T. Saunders, Brent Holmes et al. (6 authors)
International Journal of Molecular Sciences
Open Access
Published: Jan 2020
25 citations
25 citations
333 days after retraction
KPT-9274, an Inhibitor of PAK4 and NAMPT, Leads to Downregulation of mTORC2 in Triple Negative Breast Cancer Cells
Emma Cordover, Janet Wei, Chadni Patel et al. (11 authors)
Chemical Research in Toxicology
Open Access
Published: Dec 2019
35 citations
35 citations
323 days after retraction
Targeting mTOR and Metabolism in Cancer: Lessons and Innovations
Cedric Magaway, Eugene Kim, Estela Jacinto
Cells
Open Access
Published: Dec 2019
201 citations
201 citations
303 days after retraction
Sin1-mediated mTOR signaling in cell growth, metabolism and immune response
Chun Ruan, Xinxing Ouyang, Hongzhi Liu et al. (8 authors)
National Science Review
Open Access
Published: Nov 2019
18 citations
18 citations
268 days after retraction
Ras functional proximity proteomics establishes mTORC2 as new direct ras effector
Joanna Kovalski, Ronald L. Shanderson, Paul A. Khavari
Oncotarget
Open Access
Published: Aug 2019
10 citations
10 citations
202 days after retraction
Disruption of the RICTOR/mTORC2 complex enhances the response of head and neck squamous cell carcinoma cells to PI3K inhibition
Kara M. Ruicci, Paul Plantinga, Nicole Pinto et al. (13 authors)
Molecular Oncology
Open Access
Published: Aug 2019
29 citations
29 citations
183 days after retraction
A Novel Therapeutic Induces DEPTOR Degradation in Multiple Myeloma Cells with Resulting Tumor Cytotoxicity
Mario I. Vega, Yijiang Shi, Patrick Frost et al. (10 authors)
Molecular Cancer Therapeutics
Open Access
Published: Aug 2019
11 citations
11 citations
183 days after retraction
Targeting B-Raf inhibitor resistant melanoma with novel cell penetrating peptide disrupters of PDE8A – C-Raf
Connor M. Blair, Nicola M. Walsh, Bruce H. Littman et al. (5 authors)
BMC Cancer
Open Access
Published: Mar 2019
16 citations
16 citations
47 days after retraction
Targeting the mTORC2 signaling complex in B cell malignancies
Wei Liao, Gwen Jordaan, Angelica Benavides-Serrato et al. (6 authors)
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Mar 2019
1 citation
1 citation
27 days after retraction
Correction: Specific blockade of Rictor-mTOR association inhibits mTORC2 activity and is cytotoxic in glioblastoma
Angelica Benavides-Serrato, Jihye Lee, Brent Holmes et al. (8 authors)
PLoS ONE
Open Access
Published: Feb 2019
10 citations
10 citations
Same day as retraction
The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2
Joanna Kovalski, Aparna Bhaduri, Ashley Zehnder et al. (7 authors)
Molecular Cell
Open Access
Published: Jan 2019
130 citations
130 citations
27 days before retraction
mTORC Inhibitors as Broad-Spectrum Therapeutics for Age-Related Diseases
Hannah Walters, Lynne S. Cox
International Journal of Molecular Sciences
Open Access
Published: Aug 2018
74 citations
74 citations
182 days before retraction
Unmasking the impact of Rictor in cancer: novel insights of mTORC2 complex
Αναστάσιος Γκουντάκος, Sara Pilotto, Andrea Mafficini et al. (10 authors)
Carcinogenesis
Open Access
Published: Jun 2018
55 citations
55 citations
225 days before retraction
Inflammation-induced mTORC2-Akt-mTORC1 signaling promotes macrophage foam cell formation
Dipanjan Banerjee, Archana Sinha, Sudeshna Saikia et al. (9 authors)
Biochimie
Published: Jun 2018
24 citations
24 citations
245 days before retraction
Inhibitors of protein–protein interactions (PPIs): an analysis of scaffold choices and buried surface area
Ran Xu, Jason E. Gestwicki
Current Opinion in Chemical Biology
Open Access
Published: Jun 2018
236 citations
236 citations
250 days before retraction
Who does TORC2 talk to?
Jianling Xie, Xuemin Wang, Christopher G. Proud
Biochemical Journal
Published: May 2018
32 citations
32 citations
258 days before retraction
The role of RICTOR downstream of receptor tyrosine kinase in cancers
Ahlem Jebali, Nicolas Dumaz
Molecular Cancer
Open Access
Published: Feb 2018
60 citations
60 citations
356 days before retraction
Nutrient Sensing, Signaling and Ageing: The Role of IGF-1 and mTOR in Ageing and Age-Related Disease
Simon C. Johnson
Sub-cellular biochemistry/Subcellular biochemistry
Published: Jan 2018
78 citations
78 citations
401 days before retraction
Towards specific inhibition of mTORC2
Elizabeth R. Murray, Angus J.M. Cameron
Aging
Open Access
Published: Dec 2017
16 citations
16 citations
421 days before retraction
mTOR signaling in immune cells and its implications for cancer immunotherapy
Hu Zeng
Cancer Letters
Published: Sep 2017
43 citations
43 citations
518 days before retraction
Related Records
This article has multiple records in the database due to different notices:
Record #58804
Sep 08, 2023Quick Stats
Total Citations:
72
Years Since Retraction:
6.8 years
Open Access:
Yes
Last Checked:
Never